A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

scientific article

A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015. is …
instance of (P31):
systematic reviewQ1504425
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SMRV.2016.08.001
P932PMC publication ID5332351
P698PubMed publication ID27863901

P50authorLana M ChahineQ57071973
Amy W AmaraQ83458162
P2093author name stringAleksandar Videnovic
P2860cites workEvaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complicationsQ24234273
A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation studyQ24564550
'The clocks that time us'--circadian rhythms in neurodegenerative disordersQ26824646
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationQ27860581
Staging of brain pathology related to sporadic Parkinson's diseaseQ28131702
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleQ28256570
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guidelineQ28277963
The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnographyQ48497005
Impaired bed mobility and disordered sleep in Parkinson's diseaseQ48497375
Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography studyQ48497382
Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic studyQ48498679
Effect of dopamine agonists on fatigue and somnolence in Parkinson's diseaseQ48501488
Disruptions of the fornix fiber in Parkinsonian patients with excessive daytime sleepinessQ48504664
Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson diseaseQ48504747
Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's diseaseQ48505608
REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's diseaseQ48529264
Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorderQ48534352
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's diseaseQ48544098
Clinical usefulness of the Parkinson's disease sleep scaleQ48553049
Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulationQ48557687
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based studyQ48561454
Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheelQ48561634
Association between waking EEG slowing and REM sleep behavior disorder in PD without dementiaQ48602775
Assessment of sleep and sleepiness in Parkinson diseaseQ48603917
Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in east ChinaQ48099379
Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorderQ48105938
Evaluation of sleep disorders in Parkinson's disease: a comparison between physician diagnosis and self-administered questionnairesQ48110582
Daytime sleep in Parkinson's disease measured by episodes of immobilityQ48116882
Clinical REM sleep behavior disorder and motor subtypes in Parkinson's disease: a questionnaire-based studyQ48119243
Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.Q48125649
REM sleep behavior disorder in Parkinson disease: association with abnormal ocular motor findingsQ48127661
Primary sleep disorder prevalence in patients with newly diagnosed Parkinson’s diseaseQ48129611
Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanismQ28537911
The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging studyQ28727519
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchQ29547257
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.Q30419918
Excessive daytime sleepiness and subsequent development of Parkinson diseaseQ30438636
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorderQ30493368
Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort.Q30499904
Case control polysomnographic studies of sleep disorders in Parkinson's diseaseQ31028156
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative diseaseQ31108254
The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson's diseaseQ31133155
Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson's diseaseQ31144479
Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.Q33211624
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's diseaseQ33607256
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseQ33647691
Best practice guide for the treatment of REM sleep behavior disorder (RBD).Q33660579
Sleep in Parkinson's disease: a comparison of actigraphy and subjective measuresQ33808286
Observations on sleep-disordered breathing in idiopathic Parkinson's diseaseQ33812515
Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson diseaseQ33835856
Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson diseaseQ33860315
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older personsQ33957588
Sleep and circadian rhythm regulation in early Parkinson diseaseQ33992743
Daytime sleepiness and Parkinson's disease: the contribution of the multiple sleep latency test.Q33999968
Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placeboQ34086489
Daytime sleepiness in Parkinson's disease: a reappraisalQ34150079
Alterations in Polysomnographic (PSG) profile in drug-naïve Parkinson's diseaseQ34169846
Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patientsQ34195029
The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysisQ34215776
Diagnostic thresholds for quantitative REM sleep phasic burst duration, phasic and tonic muscle activity, and REM atonia index in REM sleep behavior disorder with and without comorbid obstructive sleep apneaQ34238320
REM sleep behavior disorder in Japanese patients with Parkinson's disease: a multicenter study using the REM sleep behavior disorder screening questionnaireQ34246009
Predictors of dementia in Parkinson disease: a prospective cohort studyQ34269001
Risk of sleep-disordered breathing in Parkinson's diseaseQ34299945
Application of LSVT BIG intervention to address gait, balance, bed mobility, and dexterity in people with Parkinson disease: a case series.Q34405789
Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic ManagementQ34442089
Abnormal metabolic network activity in REM sleep behavior disorderQ37658353
REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease.Q37716114
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patientsQ37733321
Scales to assess sleep impairment in Parkinson's disease: critique and recommendationsQ37798777
Testing an aetiological model of visual hallucinations in Parkinson's diseaseQ37932878
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinicQ38039066
Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunctionQ38191304
Nocturnal journey of body and mind in Parkinson's disease: the manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD studyQ38200511
Meta-analysis of the efficacy and safety of long-acting non-ergot dopamine agonists in Parkinson's diseaseQ38208548
Long-term effect of initiating pramipexole vs levodopa in early Parkinson diseaseQ38381821
Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic studyQ38386657
Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementiaQ38387848
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD.Q39051901
Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.Q39159897
Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaireQ39233404
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single doseQ39336078
Prevalence of nocturia in Parkinson's disease patients from various ethnicities.Q39344081
Idiopathic Parkinson's disease patients at the urologic clinicQ39377678
Plasma urate in REM sleep behavior disorderQ39444007
Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.Q39446817
Visual symptoms in Parkinson's disease and Parkinson's disease dementia.Q39703424
Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scaleQ40087084
Nighttime sleep problems and daytime sleepiness in Parkinson's diseaseQ40160509
Sleep disturbances in drug naïve Parkinson's disease (PD) patients and effect of levodopa on sleepQ41691668
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson’s diseaseQ42810802
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementiaQ42875934
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].Q42905495
Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's diseaseQ42905506
Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.Q42957249
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatmentQ43057272
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effectsQ43255320
Nonviolent elaborate behaviors may also occur in REM sleep behavior disorderQ43367728
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy.Q43591473
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's diseaseQ43608778
Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's diseaseQ43786637
Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over timeQ43850425
Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters.Q43935742
Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patientsQ43946880
Characteristics of obstructive sleep apnea in patients with Parkinson's diseaseQ44038772
Sleepwalking, REM sleep behaviour disorder and overlap parasomnia in patients with Parkinson's diseaseQ44049630
Depression and quality of life in monogenic compared to idiopathic, early-onset Parkinson's diseaseQ44073890
SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's diseaseQ44153415
Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.Q44183770
Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's diseaseQ48640356
The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's diseaseQ48651091
Quality of life in young- compared with late-onset Parkinson's diseaseQ48669290
Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathyQ48686296
The relation of falls to fatigue, depression and daytime sleepiness in Parkinson's diseaseQ48686419
Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndromeQ48741928
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depressionQ48805917
Psychometric evaluation of the Stanford Sleepiness ScaleQ48887333
Widespread cortical and subcortical brain atrophy in Parkinson's disease with excessive daytime sleepiness.Q48944618
"Saw-tooth" pattern in the flow-volume loopQ49036432
A "saw-tooth" pattern in Parkinson's diseaseQ49054119
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementiaQ50216645
Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.Q50725140
Prevalence and clinical profile of restless legs syndrome in Parkinson's diseaseQ51545647
Evaluation of fatigue in Parkinson's disease using the Brazilian version of Parkinson's Fatigue Scale.Q51566657
Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease.Q51650199
Fatigue in a cohort of geriatric patients with and without Parkinson's disease.Q51865199
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson diseaseQ56688228
Transdermal RotigotineQ56688229
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropiniroleQ56971074
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing resultsQ57083753
Assessing autonomic symptoms of Parkinson’s disease with the SCOPA-AUT: a new perspective from Rasch analysisQ60222446
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patientsQ62719833
Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson's diseaseQ80235684
Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson's diseaseQ83021601
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension studyQ83425577
Validation of the non-motor symptoms questionnaire (NMS-Quest)Q84943707
Abnormal ventilatory control in Parkinson's disease--further evidence for non-motor dysfunctionQ85063984
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's diseaseQ86424776
Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's diseaseQ88060366
Impaired visual perception in rapid eye movement sleep behavior disorderQ48145448
Relationship between sleep disorders and other non-motor symptoms in Parkinson's diseaseQ48160062
Transcranial brain sonography in Parkinson's disease with restless legs syndromeQ48167362
Drivers with Parkinson's disease: are the symptoms of PD associated with restricted driving practices?Q48167887
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's diseaseQ48172368
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodiesQ48172943
Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's diseaseQ48187731
Sleep disturbance in patients with Parkinson's disease presenting with leg motor restlessnessQ48190257
Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's diseaseQ48190381
Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control studyQ48199609
Motor and non-motor symptoms in Turkish patients with Parkinson's disease affecting family caregiver burden and quality of lifeQ48207453
Validation of the Innsbruck REM sleep behavior disorder inventoryQ48209401
Abnormal occipital event-related potentials in Parkinson's disease with concomitant REM sleep behavior disorderQ48215461
Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS studyQ48227407
Sleep matters in Parkinson's disease: use of a priority list to assess the presence of sleep disturbancesQ48227572
Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease?Q48230826
Subjective sleep problems in patients with early Parkinson's diseaseQ48235902
Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?Q48235911
Rapid eye movement sleep behavior disorder and subtypes of Parkinson's diseaseQ48236738
REM sleep behavior disorder in Parkinson's disease--is there a gender difference?Q48237112
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorderQ48245989
Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.Q48247525
A preliminary quantitative analysis of REM sleep chin EMG in Parkinson's disease with or without REM sleep behavior disorder.Q48252779
Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson's disease.Q48252870
Heart rate variability in patients with idiopathic Parkinson's disease with and without obstructive sleep apnea syndromeQ48256696
Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective studyQ48259289
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patientsQ48259976
Increased risk of leg motor restlessness but not RLS in early Parkinson diseaseQ48274480
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale.Q48275749
Complex paroxysmal nocturnal behaviors in Parkinson's diseaseQ48285785
Associated factors for REM sleep behavior disorder in Parkinson diseaseQ48288948
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's diseaseQ48289765
Fatigue in patients with Parkinson's disease: impact on quality of lifeQ48290623
Slowing of electroencephalogram in rapid eye movement sleep behavior disorderQ48291939
Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative studyQ48293141
Motor and non-motor correlates of olfactory dysfunction in Parkinson's diseaseQ48296062
Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's diseaseQ48296473
Towards an understanding of fatigue in Parkinson diseaseQ48298647
The impact of sleep and mood disorders on quality of life in Parkinson's disease patientsQ48301186
Relationship between sleep and dysautonomic symptoms assessed by self-report scales.Q48303345
Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorderQ48304705
Validation of the Thai SCOPA-sleep scale for assessment of sleep and sleepiness in patients with Parkinson's disease.Q48304949
Neuropsychological functioning in Parkinson's disease: differential relationships with self-reported sleep-wake disturbancesQ48308858
Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's diseaseQ48308907
Probable REM sleep behaviour disorder and STN-DBS outcome in Parkinson's DiseaseQ48309179
Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson diseaseQ48310921
How well do we recognise non-motor symptoms in a British Parkinson's disease population?Q48312842
Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).Q48316901
Parkinson's disease sleep scale--validation of the revised version PDSS-2.Q48317345
The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's diseaseQ48319936
Relation between subtype of Parkinson's disease and REM sleep behavior disorderQ36955210
No increased risk of obstructive sleep apnea in Parkinson's diseaseQ37056523
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson diseaseQ37056546
Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's diseaseQ37060398
Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networksQ37071647
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorderQ37100913
The impact of sleep quality on cognitive functioning in Parkinson's diseaseQ37136554
Daytime sleepiness is associated with falls in Parkinson's diseaseQ37170504
A controlled trial of antidepressants in patients with Parkinson disease and depressionQ37180389
Effects of sleep disorders on the non-motor symptoms of Parkinson diseaseQ37248911
Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbiditiesQ37248917
Nocturia and overnight polysomnography in Parkinson diseaseQ37255541
A comprehensive model of health-related quality of life in Parkinson's disease.Q37280767
Sleep and impulsivity in Parkinson's diseaseQ37425362
Restless legs syndrome and its associated risk factors in Parkinson's diseaseQ37433288
Restless legs syndrome: an early clinical feature of Parkinson disease in men.Q37510441
Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apneaQ37518484
Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease?Q37576274
A Neurodegenerative Disease Sleep Questionnaire: principal component analysis in Parkinson's diseaseQ37625684
Associations of sleep disturbance symptoms with health-related quality of life in Parkinson's diseaseQ37651800
Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control studyQ37657040
What are obstructive sleep apnea patients being treated for prior to this diagnosis?Q34498263
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health StudyQ34508280
Lack of polysomnographic Non-REM sleep changes in early Parkinson's diseaseQ34548263
Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaireQ34581337
REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.Q34581908
Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine.Q34585382
Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson's Disease?Q34610885
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRSQ34617020
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trialQ34619438
Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptomsQ34638941
Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease.Q34651186
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesQ34666836
The REM sleep behavior disorder screening questionnaire--a new diagnostic instrumentQ34692883
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).Q34771200
Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK).Q35014993
Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory studyQ35028869
Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease.Q35058875
Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndromeQ35059012
Sleep quality in Parkinson disease: an examination of clinical variablesQ35078570
Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patientsQ35107980
Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson's diseaseQ35141127
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trialQ35485478
The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's diseaseQ35560075
Clinical correlates of periodic limb movements in sleep in Parkinson's diseaseQ35874812
Caffeine for treatment of Parkinson disease: a randomized controlled trialQ36149963
Insomnia in Parkinson's disease: frequency and progression over timeQ36227480
Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly populationQ36380042
Daytime REM sleep in Parkinson's diseaseQ36451550
REM sleep behavior disorder in Parkinson's disease: a questionnaire-based surveyQ36477085
Sleep in essential tremor: a comparison with normal controls and Parkinson's disease patientsQ36610164
Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorderQ36626762
The spectrum of nonmotor symptoms in early Parkinson diseaseQ36659353
Non-motor symptoms of Parkinson's disease: the patient's perspectiveQ36725177
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.Q36941752
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's diseaseQ36953865
The role of mild depression in sleep disturbance and quality of life in Parkinson's diseaseQ44220201
Electroencephalographic slowing heralds mild cognitive impairment in idiopathic REM sleep behavior disorderQ44238309
Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's diseaseQ44308213
Sleep disturbances in untreated Parkinson's disease.Q44499646
Revisiting the impact of REM sleep behavior disorder on motor progression in Parkinson's diseaseQ44511600
Sleep benefit in Parkinson's disease is associated with short sleep timesQ44569386
Actigraphically-defined sleep disturbance in Parkinson's disease is associated with differential aspects of cognitive functioningQ44597462
Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodiesQ44613423
Correlates of excessive daytime sleepiness in Parkinson's diseaseQ44619342
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.Q44825538
Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of lifeQ44826435
Association of pain, Parkinson's disease, and restless legs syndromeQ44904610
Bladder dysfunction in advanced Parkinson's disease.Q44925060
Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease?Q45076738
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-offQ45122889
A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's diseaseQ45179908
Emergence of restless legs syndrome during subthalamic stimulation for Parkinson diseaseQ45205196
Excessive daytime sleepiness and its risk factors in incident Parkinson's diseaseQ45345054
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorderQ45428915
No association between neuropathy and restless legs in Parkinson's diseaseQ45738852
Subjectively impaired bed mobility in Parkinson disease affects sleep efficiencyQ45740995
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptomsQ45749080
RBD in Parkinson's disease: a clinical case control study from North IndiaQ45815060
Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritageQ46153566
Psychotic and compulsive symptoms in Parkinson's disease.Q46169445
Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter studyQ46330976
Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinationsQ46354633
Snoring is associated with an impaired motor function, disease severity and the quality of life but not with excessive daytime sleepiness in patients with Parkinson's disease.Q46464356
REM sleep behaviour disorder in Parkinson's disease is associated with specific motor featuresQ46488410
Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's diseaseQ46627313
Lower urinary tract symptoms in men with Parkinson diseaseQ46630485
Melatonin for sleep disturbances in Parkinson's diseaseQ46637940
Sudden uncontrollable somnolence and medication use in Parkinson diseaseQ46640925
Rapid eye movement sleep behavior disorder in Parkinson's disease: magnetic resonance imaging studyQ46770992
Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson diseaseQ46924171
Predictive factors for nocturia in elderly men: a cross-sectional study in 21 general practicesQ46936658
The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndromeQ46962027
Restoration of normal motor control in Parkinson's disease during REM sleepQ47582710
Polysomnographic predictors of blood pressure and hypertension: is one index best?Q47697429
Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patientsQ47766482
Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson's disease patientsQ47782385
Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's diseaseQ48005952
Impulse control disorder and rapid eye movement sleep behavior disorder in Parkinson's diseaseQ48025528
Parasomnias and isolated sleep symptoms in Parkinson's disease: a questionnaire study on 661 patientsQ48031472
Association between nocturnal/supine hypertension and restless legs syndrome in patients with Parkinson's diseaseQ48094556
Clinical features associated with sleep disturbances in Parkinson's diseaseQ48094582
Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorderQ48095208
Reduced thalamic volume in Parkinson disease with REM sleep behavior disorder: volumetric studyQ48095600
Patient-reported autonomic symptoms in Parkinson diseaseQ48097601
Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorderQ48320944
Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures.Q48322948
Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trialQ48324346
Cardiac 123I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorderQ48326527
REM behaviour disorder detection associated with neurodegenerative diseasesQ48330499
Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's diseaseQ48336115
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?Q48337791
Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's diseaseQ48340392
A 12-year population-based study of psychosis in Parkinson diseaseQ48345449
Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorderQ48347012
Parkinson's disease symptoms: the patient's perspectiveQ48349277
REM sleep behavior disorder is not linked to postural instability and gait dysfunction in ParkinsonQ48349296
Sleep patterns in Parkinson's disease patients with visual hallucinationsQ48350404
Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleepQ48351864
Lower prevalence of sleep disturbances in familial versus sporadic Parkinson's disease: a questionnaire based studyQ48354473
Excessive daytime sleepiness in Parkinson's disease: characteristics and determinantsQ48374408
Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormiaQ48382930
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementiaQ48384242
Validation of the Parkinson's disease sleep scale in Japanese patients: a comparison study using the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale and PolysomnographyQ48386386
REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream?Q48386776
Malnutrition and associated factors in Chinese patients with Parkinson's disease: Results from a pilot investigationQ48387106
Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's diseaseQ48391906
Is obstructive sleep apnea a problem in Parkinson's disease?Q48393802
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's diseaseQ48398056
Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS.Q48403662
Patterns of motor and non-motor features in Parkinson's disease.Q48409698
Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian versionQ48409726
Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences?Q48413323
Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsyQ48420586
Manifestations of Parkinson disease differ in association with REM sleep behavior disorderQ48426386
Predictors and course of health-related quality of life in Parkinson's diseaseQ48433831
REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.Q48433835
STOP questionnaire: a tool to screen patients for obstructive sleep apneaQ48436814
Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's diseaseQ48439627
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptomsQ48440050
Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and familiesQ48450074
The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's diseaseQ48450083
Excessive daytime sleepiness in Parkinson disease: a SPECT studyQ48452421
Case-control study of restless legs syndrome and quality of sleep in Parkinson's diseaseQ48454144
Restless legs syndrome in Parkinson's diseaseQ48464367
Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scaleQ48466407
A nationwide survey of excessive daytime sleepiness in Parkinson's disease in FranceQ48467673
Bright light therapy in Parkinson's disease: a pilot studyQ48468410
Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled studyQ48473078
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson diseaseQ48473116
Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's diseaseQ48476633
Driving with distraction in Parkinson diseaseQ48484285
Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's diseaseQ48485654
Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?Q48490629
Mood and sleep in Parkinson's disease.Q48494938
P921main subjectsystematic reviewQ1504425
sleepQ35831
Parkinson's diseaseQ11085
P304page(s)33-50
P577publication date2016-08-31
P1433published inSleep Medicine ReviewsQ15716616
P1476titleA systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015
P478volume35

Reverse relations

cites work (P2860)
Q64863522Q64863522
Q64865258Q64865258
Q64878090Q64878090
Q90470076A 10-Year Follow-Up of Excessive Daytime Sleepiness in Parkinson's Disease
Q41501356A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD).
Q91738117Association between circadian rhythms and neurodegenerative diseases
Q55456108Circadian and Homeostatic Modulation of Multi-Unit Activity in Midbrain Dopaminergic Structures.
Q58760662Clinical Predictors of Excessive Daytime Sleepiness in Patients with Parkinson's Disease
Q38647726Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series.
Q58700828Deep Brain Stimulation and Sleep-Wake Disturbances in Parkinson Disease: A Review
Q47753232Diagnostic accuracy of REM sleep behaviour disorder screening questionnaire: a meta-analysis
Q53406124Disturbances of Sleep and Alertness in Parkinson's Disease.
Q55618860Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?
Q47657737Effects of Exercise on Non-motor Symptoms in Parkinson's Disease
Q90174256Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism
Q52583507Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management.
Q64867863Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men
Q90203947Factors related to sleep disturbances for individuals with Parkinson's disease: a regional perspective
Q88687003Idiopathic Hypersomnia
Q90325236Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Q38758058Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease
Q57454213Low-Grade Inflammation Aggravates Rotenone Neurotoxicity and Disrupts Circadian Clock Gene Expression in Rats
Q94561297Nonmotor Symptoms Affect Sleep Quality in Early-Stage Parkinson's Disease Patients With or Without Cognitive Dysfunction
Q47204114Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients
Q90186870Presleep Cognitive Arousal and Insomnia Comorbid to Parkinson Disease: Evidence for a Serial Mediation Model of Sleep-Related Safety Behaviors and Dysfunctional Beliefs About Sleep
Q94586424REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes
Q64780258Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease
Q33634088Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond
Q41620763Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?
Q97886916Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila
Q47659714SLEEP AND CIRCADIAN RHYTHM DISORDERS IN PARKINSON'S DISEASE.
Q99414223Shedding Light on Nocturnal Movements in Parkinson's Disease: Evidence from Wearable Technologies
Q54947557Sleep Disorders in Parkinson's Disease: Present Status and Future Prospects.
Q92947665Sleep Disturbance as Potential Risk and Progression Factor for Parkinson's Disease
Q91633928Sleep and risk of parkinsonism and Parkinson's disease: a population-based study
Q55221111Sleep disturbances and depression severity in patients with Parkinson's disease.
Q92988505Sleep in Parkinson's disease
Q47223743Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
Q57485185Spatial disorientation and executive dysfunction in elderly nondemented patients with Parkinson's disease
Q93013689Striatum Shape Hypertrophy in Early Stage Parkinson's Disease With Excessive Daytime Sleepiness
Q64767243The Parkinson's Disease Sleep Scale-2 (PDSS-2): Validation of the Spanish Version and Its Relationship With a Roommate-Based Version
Q39342961Treatment of Sleep Dysfunction in Parkinson's Disease.
Q64108391White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness

Search more.